SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is surging amid CEO Jeff Green's substantial $148 million insider share purchase and reports of early talks with OpenAI to power ChatGPT's ad sales, igniting community discussion about a potential short squeeze for the previously oversold stock.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI is trending after announcing strong earnings and robust revenue guidance, coupled with securing new defense contracts for missile propulsion and an Air Force project advancing multi-domain swarming autonomy. This news is driving intense community discussion on its potential as a disruptive force in defense AI, particularly amidst high short interest and market volatility.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending after reporting strong earnings, showcasing accelerating AI chip revenue, and providing an ambitious forecast of over $100 billion in AI chip sales by 2027, backed by expanded partnerships with major hyperscalers. The community is weighing this significant AI infrastructure growth against historical post-earnings volatility and current valuation concerns.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending following its latest earnings report, which showcased strong revenue and user growth but stirred community debate over an initial conflicting EPS report and higher operating expenses. While many see long-term potential in its expanding user base and global strategy, concerns about profitability and ongoing dilution keep sentiment divided within the fintech space.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending following its earnings report and conservative 2026 guidance, which has fueled investor frustration over the stock's valuation and the projected impact of the TDAPA cliff on DefenCath revenue. The community is actively debating if the announced $75 million share buyback can counter persistent short interest and management's cautious outlook, while awaiting key REZZAYO trial results and potential Medicare Advantage contract updates.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is actively debated following its latest earnings report, which detailed substantial share buybacks and a new dividend, alongside increased investments in AI and new ventures like food delivery impacting profitability. Community sentiment is sharply divided, with some emphasizing long-term value and significant cash reserves, while others express frustration over fierce competition and the stock's persistent decline.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is facing intense community debate following a recent earnings report that highlighted declining revenue and widening losses. This financial performance is fueling widespread skepticism over the company's multi-billion-dollar market capitalization and perceived slow progress within the highly speculative quantum computing sector, with many drawing comparisons to competitors like IonQ.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending after appointing former Pfizer CMO Dr. Freda Lewis-Hall to its board, a move seen by the community as a significant credibility boost amidst recent positive Phase 2 results for its generalized anxiety disorder treatment and anticipation for upcoming Phase 3 data in major depressive disorder. Despite past performance concerns and low trading volume, investors are actively discussing the company's strong pipeline and institutional accumulation, believing the stock is currently undervalued.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is gaining attention following a substantial government award aimed at expanding its domestic antimony supply chain, a critical mineral for defense, sparking community discussions around its strategic importance, short interest, and significant long-term growth potential amidst global supply concerns.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as CEO Greg Abel's significant personal stock purchase and the resumption of share buybacks signal strong confidence in the company's future, with the community actively debating the ongoing capital allocation strategy given its substantial cash reserves and the leadership transition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ADC Therapeutics (NYSE:ADCT) Sees Strong Trading Volume - Here's What Happened

ADC Therapeutics (NYSE:ADCT) Sees Strong Trading Volume - What's Next...

ADC Therapeutics SA (NYSE:ADCT) Receives Average Rating of "Moderate Buy" from Brokerages

ADC Therapeutics SA (NYSE:ADCT - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five analysts that are presently covering the firm, MarketBeat reports. One research...

ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026

ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026 ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference...

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire LAUSANNE, Switzerland, March 2, 2026 LAUSANNE...

ADC Therapeutics to Participate in March Investor Conferences

ADC Therapeutics to Participate in March Investor Conferences ADC Therapeutics to Participate in March Investor Conferences PR Newswire LAUSANNE, Switzerland, Feb. 24, 2026 LAUSANNE, Switzerland...

ADC Therapeutics (NYSE:ADCT) Shares Up 6.7% - Time to Buy?

ADC Therapeutics (NYSE:ADCT) Trading 6.7% Higher - What's Next...

ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement

ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement PR Newswire LAUSANNE, Switzerland, Feb. 23, 2026...

ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of ADC Therapeutics SA (NYSE:ADCT - Get Free Report) have received an average rating of "Moderate Buy" from the six analysts that are covering the stock, Marketbeat.com reports. One equities...

ADC Therapeutics (NYSE:ADCT) Trading Down 4.5% - Here's What Happened

ADC Therapeutics (NYSE:ADCT) Trading Down 4.5% - Here's Why...

ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5% - Here's Why

ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5% - What's Next...

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.

ADCT
Adc Therapeutics SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ADCT News

ADCTAdc Therapeutics SA